Different from intrinsic T cell receptor (TCR)-mediated tumour recognition, CAR-based antitumour effects circumvent the immune evasion mechanisms of tumour cells by virtue of an MHC unrestricted antigen recognition mode. Here, HLA-C is linked to neoplasm.